Skip to main content

Table 2 In-hospital management according to treatment groups

From: Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS)

  

DPP4i

Metformin

Other Oral

p Value

  

n = 31

n = 348

n = 66

 
 

Aspirin (%)

96.8

97.1

97.0

0.99

 

Clopidogrel (%)

96.8

92.2

90.9

0.59

*

LMW Heparin (%)

48.4

52.6

48.5

0.77

UF Heparin (%)

46.7

37.1

36.4

0.57

ACE Inhibitors (%)

76.7

72.1

60.6

0.13

§

ARB (%)

10.0

14.1

9.1

0.48

 

Beta Blockers (%)

87.1

82.8

77.3

0.43

 

Statins

93.5

96.0

95.5

0.81

Coronary interventions during admission

   
 

STEMI reperfusion (%)

71

66

52

0.06

||

PCI (%)

70.4

72.0

58.3

0.24

 

Coronary stenting (%)

88.9

88.7

81.0

0.58

 

Coronary bypass Surgery (%)

11.1

5.6

13.9

0.12

  1. ‡ACEIs – Angiotensin Converting Enzyme.
  2. §Angiotensin Receptor Blockers.
  3. *LMW – Low Molecular Weight.
  4. ||PCI – Percutaneous Coronary.
  5. Intervention.
  6. †UF – Unfractionated